The latest research showed that Enhydrin inhibits the EMT process of GBM through the Jun/Smad7/TGF‐β1 signaling pathway, leading to a significant decrease in cell proliferation, invasion, and migration. This evidence concerns the gene TGFB1 and glioblastoma.